Ningxia Zhongwei: Electrical Beauty Countryside Abundant Scene
ZHONGWEI, China, Oct. 28, 2024 /PRNewswire/ — “When harvesting corn, we must pay attention to the safety distance between the harvester and the poles and wires!” On October 14, the State Grid Zhongwei Power Supply Company conducted a “net-type” inspection of agricultur
European tour opens up opportunities for Shanxi’s businesses
BEIJING, Oct. 28, 2024 /PRNewswire/ — A report from China Daily Shanxi province recently showcased its investment and trade opportunities to the European business community with promotional events held in the United Kingdom and Spain. The events, running from Oct 7-15, were part of a large pr
International Paper CEO to Speak at Baird 2024 Global Industrial Conference
MEMPHIS, Tenn., Oct. 28, 2024 /PRNewswire/ — International Paper Chief Executive Officer Andy Silvernail will speak at the Baird 2024 Global Industrial Conference on Thursday, November 14, 2024. The presentation is scheduled to begin at 8:30 a.m. Eastern time and will be followed by a questio
Azul Celebrates Successful Negotiations with Partners and Announces Strengthened Financial Position
After being affected by several external factors, such as exchange rate fluctuations and challenges in the global aviation supply chain, Azul announces the completion of negotiations with aircraft lessors and the signing of a support agreement with its main creditors, establishing an enhanced financ
FluidAI Collaborates with Mayo Clinic Platform to Develop AI-Driven Postoperative Monitoring Solutions
FluidAI will utilize Mayo Clinic Platform’s extensive de-identified clinical data to enhance predictive algorithms, aiming to improve patient outcomes in postoperative care. KITCHENER, ON, Oct. 28, 2024 /PRNewswire/ – FluidAI Medical (FluidAI), a leader in artificial intelligence (AI)-dr
TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn’s disease
A greater number of patients treated with subcutaneous TREMFYA® induction and maintenance achieved clinical and endoscopic remission at 48 weeks in the Phase 3 GRAVITI study versus placebo TREMFYA® could become the first IL-23 treatment to offer both a subcutaneous and intravenous (IV) induction r
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
Company’s Booth Spotlights Comprehensive Hip Portfolio and Enabling Technologies Including OrthoGrid Hip AI® and HAMMR™ Automated Hip Impaction System WARSAW, Ind., Oct. 28, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today
22 wineries from Rioja Alavesa, Txakoli and Cider from the Basque Country are presenting their high-quality products in Japan
TOKYO, Oct. 28, 2024 /PRNewswire/ — The Minister of Food, Rural Development, Agriculture and Fisheries of the Basque Government, Amaia Barredo, leads a trade mission made up of representatives of 22 Basque wineries of white and red wines from Rioja Alavesa, Txakoli and Cider Euskal Sagardoa th
Mitsubishi Outlander Tops Segment in Critical J.D. Power Multimedia Study
J.D. Power releases “2024 U.S. Multimedia Quality and Satisfaction Study” Mitsubishi Outlander named best multimedia system in “small/compact” segment Customer satisfaction drives Outlander to 2024 sales success FRANKLIN, Tenn., Oct. 28, 2024 /PRNewswire/ — In-car techn
TrueBlue’s PeopleReady Earns Top Recognition as a Leader in U.S. Industrial Contingent Talent and Strategic Solutions by Everest Group
TACOMA, Wash., Oct. 28, 2024 /PRNewswire/ — PeopleReady, a TrueBlue company (NYSE: TBI), has been recognized as a Leader, the highest distinction, on leading research firm Everest Group’s U.S. Industrial Contingent Talent and Strategic Solutions PEAK Matrix® 2024. This marks a second co
